Interface entre neuropsicologia e psicopatologia: funções executivas, variáveis clínicas, qualidade de vida e funcionalidade na depressão e no transtorno bipolar

• Ano de defesa: 2015
• Autor(a) principal: Cotrena, Charles
• Orientador(a): Fonseca, Rochele Paz
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Pontifícia Universidade Católica do Rio Grande do Sul
• Programa de Pós-Graduação: Programa de Pós-Graduação em Psicologia
• Departamento: Faculdade de Psicologia
• País: Brasil
• Palavras-chave em Português: PSICOLOGIA COGNITIVA; NEUROPSICOLOGIA; PSICOPATOLOGIA; TRANSTORNO BIPOLAR; FUNÇÃO EXECUTIVA
• Área do conhecimento CNPq: CIENCIAS HUMANAS::PSICOLOGIA
• Link de acesso: http://tede2.pucrs.br/tede2/handle/tede/6274

Several neuropsychological and psychopathological studies have sought to identify the cognitive features associated with different psychiatric conditions and their relationship with clinical and demographic variables, functioning and quality of life. Major depressive (MDD) and bipolar disorder (BD) have been the subject of several such investigations, although findings are still preliminary and limited in their clinical applicability and generalizability due to the methodological heterogeneity of studies in the area. Therefore, the goal of this research was to investigate the relationship between cognitive, clinical and demographic features as well as quality of life and functioning in a naturalistic sample of patients with MDD and TB as compared to healthy subjects. The first study investigated differences between the cognitive performance of patients with MDD, BDI, BDII and adults with no mood disorders. Patients with MDD showed impairments in sustained and divided attention, working memory, verbal fluency, inhibitory control and decision making, especially in timed tasks. Patients with BDII showed variable performance and high rates of impairment in attentional interference control. Finally, patients with BDI showed consistently poorer performance than the remaining groups on most cognitive tasks, as well as greater impairments in attention and inhibition than individuals with MDD. In light of these findings and studies regarding the variability of cognitive profiles within diagnostic categories, the second study aimed to identify executive functioning profiles in mood disorders using hierarchical cluster analysis. Four distinct groups of participants were identified. The first was characterized by the absence of executive impairment and was mostly composed of control participants, while the second group showed slight impairments in inhibitory control, divided attention, working memory and verbal fluency. Clusters 3 and 4, composed clinical participants only, showed impairments in inhibitory control and working memory (cluster 3), and inhibitory control and cognitive flexibility (cluster 4). Given the heterogeneity of profiles identified, and the known impact of cognition on functional outcome and quality of life in mood disorders, the third study sought to identify profiles of functioning and quality of life in MDD and BD, as well as their association with clinical, demographic and cognitive variables. The subscales of the WHODAS 2.0 and WHOQOL-BREF questionnaires were submitted to a hierarchical cluster analysis, which assigned patients into three groups. The first, composed mostly of control participants and a small percentage of psychiatric patients, had the highest scores on these measures. The second group obtained intermediate scores, and contained mostly individuals with MDD and BDII, and, to a lesser extent, BDI and control participants. Lastly, cluster 3 had the worst overall performance and was composed predominantly of patients with TBI, and some patients with TBII and TDM. No control participants were included in this group. Poor functioning and quality of life were associated with impairments in inhibitory control, decision making and attentional control. Together, these studies provided important data regarding cognition, functioning and quality of life in mood disorders, revealing a continuum of severity and several possible targets for therapeutic approaches developed specifically for these diagnostic categories.